Increased pulmonary vascular resistance independently predicts acute exacerbation-related hospitalization in patients with COPD-PH.

In March, we reported on back-to-back FDA approvals for two treatments in pulmonary arterial hypertension (PAH). In this report, we follow up on what has happened since. After the FDA approved both ...

AJMC: Can you explain the etiology and progression of PAH and the importance of early diagnosis? HASSOUN: Pulmonary arterial hypertension (PAH) refers to World Health Organization (WHO) group 1 ...

Your body is constantly performing a delicate balancing act that most of us never think about. While we’re busy worrying about calories and carbs, a microscopic chemistry experiment determines how ...